Levofloxacin (oral): Difference between revisions
No edit summary |
No edit summary |
||
| Line 7: | Line 7: | ||
==Overview== | ==Overview== | ||
'''Levofloxacin''' (trade names '''Levaquin''' (US), '''Tavanic''' (EU), and others) is a broad spectrum [[antibiotic]] of the [[fluoroquinolone]] drug class, | '''Levofloxacin''' (trade names '''Levaquin''' (US), '''Tavanic''' (EU), and others) is a broad spectrum [[antibiotic]] of the [[fluoroquinolone]] drug class, | ||
and the levo isomer of its predecessor [[ofloxacin]]. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections. | |||
Revision as of 04:43, 9 January 2014
Template:Levofloxacin Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]
For patient information, click here.
Overview
Levofloxacin (trade names Levaquin (US), Tavanic (EU), and others) is a broad spectrum antibiotic of the fluoroquinolone drug class, and the levo isomer of its predecessor ofloxacin. Its spectrum of activity includes most strains of bacterial pathogens responsible for respiratory, urinary tract, gastrointestinal, and abdominal infections.
Category
Fluoroquinolone, third generation.
US Brand Names
LEVAQUIN®, LEVOFLOXACIN®.
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | How Supplied | Labels and Packages